ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,000 | -33.3% | 1,706 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -64.7% | 1,706 | 0.0% | 0.00% | – |
Q1 2021 | $17,000 | -29.2% | 1,706 | -23.0% | 0.00% | – |
Q4 2020 | $24,000 | +4.3% | 2,216 | 0.0% | 0.00% | – |
Q3 2020 | $23,000 | -50.0% | 2,216 | 0.0% | 0.00% | – |
Q2 2020 | $46,000 | +475.0% | 2,216 | -7.6% | 0.00% | – |
Q4 2017 | $8,000 | – | 2,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |